Nimustine hydrochloride

Base Information

• Chemical Name: Nimustine hydrochloride
• CAS No.: 55661-38-6
• Deprecated CAS: 52208-23-8
• Molecular Formula: C9H13ClN6O2.ClH
• Molecular Weight: 309.15
• European Community (EC) Number: 624-091-7,678-313-2
• NSC Number: 245382
• UNII: DFR965WKBU
• DSSTox Substance ID: DTXSID80204185
• Wikidata: Q27107532
• NCI Thesaurus Code: C95325
• Metabolomics Workbench ID: 53324
• ChEMBL ID: CHEMBL1256616
• Mol file: 55661-38-6.mol

Synonyms:ACNU;Nimustine;NSC 245382

Chemical Property of Nimustine hydrochloride

Chemical Property:

• Appearance/Colour: white to light yellow solid.
• Melting Point: 186°C(lit.)
• Boiling Point: 471.6 °C at 760 mmHg
• Flash Point: 239 °C
• PSA: 113.57000
• LogP: 2.57310
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• Solubility.: soluble in Methanol
• Hydrogen Bond Donor Count: 3
• Hydrogen Bond Acceptor Count: 6
• Rotatable Bond Count: 4
• Exact Mass: 308.0555291
• Heavy Atom Count: 19
• Complexity: 292

Purity/Quality:

99% ^*data from raw suppliers

Nimustine Hydrochloride ^*data from reagent suppliers

Safty Information:

• Pictogram(s): T
• Hazard Codes: T
• Statements: 25
• Safety Statements: 36/37/39-45

MSDS Files:

SDS file from LookChem

Total 1 MSDS from other Authors

Useful:

• Canonical SMILES: CC1=NC=C(C(=N1)N)CNC(=O)N(CCCl)N=O.Cl
• Recent EU Clinical Trials: Lókoregionale Tiefenhyperthermie begleitend zu ACNU in der Rezidivtherapie von Patienten mit malignen Gliomen (WHO°III/IV)- Phase I/II-Studie
• Recent NIPH Clinical Trials: Phase II multicenter investigator initiated trial of Convection-enhanced delivery of Nimustine Hydrochloride against brainstem gliomas